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Summary.-We have measured post-irradiation recovery (potentially lethal damage
repair) after fractionated radiation in plateau-phase cultures of two human tumour
cell lines derived from tumours of different radiocurabilities (melanoma and breast).
Although the radiation survival-curve parameters of these cell lines are similar, the
repair of potentially lethal X-ray damage after fractionated X-ray treatment
conferred significant radioresistance on the human melanoma cells but not the
human breast carcinoma cells. Wesuggest that therepairofpotentiallylethaldamage
may correlate with clinical radiocurability.
ALTHOUGH IONIZING RADIATION has
become an integral part ofmodern human
cancer therapy, the biological explanation
of therapeutic success or failure remains
elusive (Kaplan, 1970, 1974). Much
evidence indicates that human tumour
cells are not intrinsically more sensitive to
the lethal effects of X-rays than are
normal tissue cells (Weichselbaum et al.,
1980; Smith et al., 1978). Pioneers in
radiation therapy determined empirically
that radiation given in multiple small
doses had a higher therapeutic ratio than
radiation delivered as a large single dose;
the radiobiological basis for this phenom-
enon is also not clear. Attempts to explain
the fractionation effects as well as failure
of radiation treatment have focused on a
number of factors including the presence
ofhypoxic cells in tumours (Kaplan, 1974;
Adams et al., 1976; McNally, 1973;
Thomlinson & Gray, 1955), and the
efficient repair of sublethal damage by
surviving tumour cells (Elkind & Sutton,
1959), as well as possible differences in the
intrinsic X-ray sensitivity of tumour cells
vs normal tissue (Weichselbaum et al.,
1980; Smith etal., 1978; Barendsen, 1980).
However, these areas ofinvestigationhave
not led to a total understanding of the
reason why some human tumours are
refractory to radiation treatment.
When monolayer cultures of mam-
malian cells are maintained under
conditions of constant medium renewal
without subculture, they enter a crowded,
density-inhibited state of growth in
which the number of dividing cells is
reduced and a large population of non-
proliferating cells develops. This physio-
logical condition may resemble the state
which exists amongst populations of
tumour cells in vivo (Little, 1969; Hahn &
Little, 1972). Such plateau-phase cultures
have thus been proposed as useful in vitro
models with certain proliferative kinetics
characterstic of in vivo tumours, in par-
ticular a population of non-cycling but
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viable cells (Hahn & Little, 1972; Zin-
ninger & Little, 1973). When plateau-
phase cultures are treated with X-rays or
chemical agents and subculture ofthe cells
to low density (a stimulus to proliferation
amongst the non-cycling cellpopulation) is
delayed, an enhancement in survival
occurs. Thisphenomenon hasbeenreferred
to as reflecting recovery from potentially
lethal X-ray damage (PLDR) and is
analogous to liquid-holding recovery in
bacteria and yeast (Little, 1969; Hahn &
Little, 1972). This type of recovery has
been described in solid and ascites tumours
in experimental animals as well as in
established human tumour celllines (Hahn
et at., 1974; Little et al., 1973; Weichsel-
baum et at., 1982; Shipley et al., 1975).
We have recently described two human
melanoma cell lines and a human osteo-
sarcoma cell line which are especially
proficient inthe repair ofpotentially lethal
X-ray damage (PLD) as compared with
other human tumour lines or normal
human diploid fibroblasts (Weichselbaum
et al., 1982). Although one of the human
melanoma lines was unusually resistant to
the lethal effects of single doses of X-rays
(survival curve Do=2'11 Gy), the Do for
the osteosarcoma line and other melanoma
line ranged between 1-40 and 1-50
Gy-well within the range of normal cells
(Weichselbaum et al., 1982). As in most
prior determinations of the radiosensi-
tivity of human cells in vitro, these
survival experiments were carried out on
cells irradiated during rapid exponential
growth.
A major factor in the failure of X-rays
to sterilize a malignant tumour could be
the ability of its non-cycling cells to
recover from PLD. In the present
investigation, we have examined the
magnitude and effects of this type of
recovery after fractionated radiation
exposure to plateau-phase cultures con-
taining cells derived from a tumour
considered to be of low radiocurability
(malignant melanoma) and cells derived
from a tumour considered to be of high
localradiocurability (breast carcinoma).
MATERIALS AND METHODS
A clonally derived human melanoma line
(C-143) and a clonally derived human breast
carcinoma line (MCF-7) weregrown inEagle's
minimal essential medium supplemented with
15% foetal calfserum, 900 mg/l ofglucose, 0-6
mg/l of sodium pyruvate and 15 mg/l of
gentamicin (Chen, 1978; Soule et at., 1973).
The cells were maintained in a humidified
atmosphere of 95% air and 5% CO2. All
radiations were carried out on a 220 KVP
G.E.MaximarX-raygeneratoroperating at 15
mA and yielding a dose rate of0-8 Gy/min to
the cells.
The experiments to examine the repair of
PLD were performed as follows. Cells were
initially seeded into 6 cm plastic Petri dishes
(Falcon) and grown to confluency. Culture
medium was then renewed for 3 days and the
experiments performed on the 4th. The cells
were irradiated at room temperature. After
radiation, dishes were returned to the
incubator; single dishes were removed and
cells subcultured and seeded at low density at
regular intervals thereafter. The number of
cells seeded ranged from 5 x 102 to 104
depending upon the radiation dose. Recovery
was measured as the enhancement in survival
as measured by colony-forming ability result-
ing from the delay in subculture; it is plotted
in terms ofsurviving fraction as a function of
the time interval between radiation and sub-
culture after a single dose ofradiation.
To measure recovery after fractionated
radiation exposure, replicate cultures were
exposed to 1, 2, 3, or 4 equal fractions of 1-25
or 1-75 Gy each delivered at successive 2h
intervals. The cells were subcultured im-
mediately after the last dose in one group of
cultures, whereas in another subculture was
delayed for 24 h. Thus the survival point for
the first group reflects a delay in subculture of
0, 2, 4, or 6 h after the first X-ray dose,
whereas for the second group it represented
24,26, 28, and 30 h total recovery time (delay
after the first dose). The doses were chosen so
that the 0 h (initial surviving) level would be
equivalent for both cell types.
RESULTS
Fig. 1 shows the enhancement in
survival resulting from PLDR in lines C-
143 and MCF-7 irradiated in density
inhibited plateau-phase growth with a
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the last dose and repair may have occured
between fractions. For example, the 1*75
Gy x 4 C-143 culture received 4 doses of
1 75Gyseparatedbythree2hintervalswith
immediate explant after the last dose; this
would allow 6 h PLD repair time for the
'/-4
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FIG. 1.-Repair of potentially lethal X-ray
damage in human melanomaline C-143 and
human breast cancer line MCF-7 as mani-
fest by an enhancement in survival after
delay in subculture. Recovery after X-ray
is 6-2-fold in the melanoma and 2-fold in
the breast cancer cells.
single dose of 7 or 5 Gy. The surviving
fraction is shown on the ordinate as a
function of time allowed after-irradiation
before subculture and reseeding to low
density. The enhancement in survival
after a 24 h delay is approximately 6-2-fold
in the C-143 line and 2-fold in the MCF-7
line.
Fig. 2(a) shows the effects on ultimate
survival of 1-4 doses of 1-75 Gy, each
separated by 2 h, in density inhibited
plateau-phase C-143. Fig. 2(b) shows
similar results for 1-4 doses of 1-25 Gy in
MCF-7 cells. Data points at 0, 2, 4 and 6 h
represent survival in culture explanted
immediately after the last dose. The
melanoma cultures thus received a total of
1-75, 3*5, 5-25 or 7 Gy and the breast
cancer cultures 1-25, 2-50, 3-75 and 5.0
Gy. In all except the single-dose groups,
some repair of potentially lethal damage
may contribute to the survival level
shown, since subculture was delayed until
ls.a
C o
z
- 0.1 I- -
4
0
z
n .0L
U)
z
0
L.O
C- 143 MELANOMA (a)
,l
"' 7Gy
'1
6 i 4 6 24 26 28 30
HOURS BETWEEN TOTAL DOSE AND EXPLANT
MCF-7 BREAST CARCINOMA (b)
' 5
5 Gy
0 2 4 6 24 26 28
HOURS BETWEEN TOTAL DOSE AND EXPLANT
FIG. 2. Effects of fractionated X-rays on
plateau cultures of human melanoma line
C-143 (a) and human breast cancer line
(MCF-7 (b). Dashed line in each figure
represents control experiments of.a single
dose (7 or 5 Gy) performed at the same time
as fractionated experiments.
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first 1'75 Gy dose, 4 h for the second, etc.
The 24, 26, 28 and 30h points in Fig. 2
represent cultures irradiated as above but
allowed 24 h recovery time after the last
dose before subculture. The dashed lines
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below represent controls irradiated with a
single dose of5 or 7 Gy at the same time as
the first dose of the fractionated groups
(subcultured at 0, 6, and 24 h). The
recovery in these controls is consistent
with that seen in Fig. 1.
Fig. 3(a) shows a single dose survival
curve (n= 1-2, DO = 151) for exponentially
growing C-143 cells compared with a
survival curve derived from the data
points from Fig. 2(a) for fractionated
exposure with a 24 h recovery interval.
Fig. 3(b) shows a single dose survival curve
for exponentially growing human breast
carcinoma line MCF-7 (n= 1 3, D0= 134)
compared to data points derived from Fig.
2(b) for fractionated exposure with a 24 h
recovery interval. The fractionated expo-
sure results in both instances represents
the overall survival including both sub-
lethal and potentially lethal damage repair
occurring during and after irradiation.
Note that in the melanoma cultures 35%
of the cells survived 7 Gy as compared
with about 1% in exponentially growing
cultures. Following a single dose of 7 Gy
when PLDR alone was active, survival
was about 13% in the case of C-143
melanoma cells. For the human breast
cancer line MCF-7, survival following
fractioned radiation was 3% after single-
dose radiation and 6% after fractionated
radiation. Survival after 24h PLD
recovery was 4%.
The differences in the responses of the
two cell lines is evident in Fig. 4, in which
survival in the C-143 melanoma and MCF-
7 cells are compared after fractionated
irradiation with 24 h recovery after the
last dose. The overall Do for the former
cells is 8-6 Gy whereas for the latter it is
only 1-76 Gy. Thus the melanoma line
FIG. 3. Survival points obtained after frac-
tionated radiation exposure and 24h PLD
repair time compared to survival curves
generated on exponentially growing human
melanoma and breast cancer cells. Signifi-
cant radioresistance is conferred on the
human melanoma cells (a) (Do= 8-6). This
radioresistance is not observed after frac-
tionated exposure in the breast cancer
line (b) (Do= 1-76).
535
GyR. R. WEICHSELBAUM AND J. B. LITTLE
FRACTIONATION EXPOSURE + 24 HOUR PLDr
T- r-ALAx Is AM^AA
z
0 .1X
U.
z MCF-7
> BREAST CARCINOMA
.01_
3 i
DOSE (Gy
FiG. 4.-Comparison of 24h repair time
survival points after fractionated radio-
therapy in plateau-phase human melanoma
line C-143 and human breast cancer line
MCF-7. Significant differences in radio-
sensitivity are seen between the se cell lines
(Do=860 Do vs= 176).
appears much more radioresistant after
fractionated radiation, whereas for the
breast carcinoma the difference after
single-dose exposure to exponentially
growing cells (Fig. 3) was minimal
(Do= 151 vs 1 34 Gy).
DISCUSSION
These results confirm our previous
finding that tumour cells with similar
radiobiological survival-curve parameters
may possess a differential ability to
manifest post-irradiation recovery ex-
pressed as the ability to repair PLD
(Weichselbaum et al., 1982). The C-143
human melanoma cells (derived from a
tumour difficult to cure with X-ray
therapy) treated with fractionated radia-
tion in vitro show a muchgreater surviving
fraction (Fig. 4) than would be predicted
with a multifractionated scheme which
includes only a simple recapitulation ofthe
shoulder region of the survival curve. The
predicted surviving fraction at 1-75 Gy in
the C-143 cells is 0 4. Thus after 4 fractions
the predicted survival with only recap-
itulation of the shoulder is (0.4)4 or 0-026.
When post-irradiation PLD recovery
occurred, the actual surviving fraction was
0 35 (Fig. 3(a)). This difference between
predicted and actual survival will increase
with increasing number of fractions and
total dose. Thewidthofthe shoulderofthe
survival curve (n) is thought to represent
the ability of cells to repair sublethal
damage, and it has been suggested that
sublethal damage repair accounts for
tumour-cell recovery after each dose in
clinical radiotherapy. The amount of
recovery after fractionated irradiation in
the MCF-7 human breast cancer line
(derived from a locally radiocurable
tumour) is only slightly greater than
predicted from a multifractionated scheme
which includes only recapitulation of the
shoulder. The predicted surviving fraction
is (0.5)4 or 0-063 as compared with 0-06
actually observed (Fig. 3(b)).
When the responses to fractionated
radiation of the 2 tumour lines are com-
pared (Fig. 4), the Dos are 8-6 (C-143) and
1 76 (MCF-7). Thus the ability to repair
PLD appears to confer significant radio-
resistance not predicted by conventional
survival-curve parameters. We propose
that this phenomenon may explain the
differences in the clinical response of some
histological tumour types to fractionated
radiation. Since the amount of post-
irradiation recovery is not predicted by
survival-curve analysis, clonogenic assays
which examine only exponential survival
and purport to predict clinical efficiency
may be misleading (Salmon et al., 1978).
This observation may well extend to the
effects of some chemotherapeutic agents,
since PLD recovery has been described
following exposure to cytotoxic agents as
well as ionizing radiation (Twentyman,
1979).
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In earlier studies, Zinninger & Little
(1973) found that plateau-phase cells were
efficient in the repair of X-ray damage
induced by large doses (10 Gy), and that
fractionated radiation was only slightly
less effective in killing plateau-phase cells
than a large single dose. Although our
present fractionation schedule is not
directly comparable to theirs, our data are
qualitatively similar. It is well known that
for equivalent total doses large dose
fractions produce more normal tissue
damage than small fractions (Harris &
Levene, 1976). Our data suggest, however,
that this difference may be minimal in
tumour cells efficient in PLDR. Thus,
recently proposed fractionation schemes
which employ large individual fractions
may be a poor overall treatment strategy
for radiotherapy, especially where good
long-term normal tissue function and a
cosmetic result are essential (Habermalz &
Fischer, 1976). Furthermore, the data
suggest that extrapolation from survival
data based on exponentially growing cells
might be misleading in the evaluation of
the radiosensitivity ofa tumour, especially
ifit contains cells proficient in PLDR.
Our results are important in that they
suggest an in vitro correlation with pos-
sible clinical results from fractionated
radiotherapy in specific tumour histo-
logical subtypes, and suggest that
recovery processes manifested in the post-
irradiation period may be the major
cellular determinant ofradiocurability.
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